Publication date: Dec 01, 2024
The COVID-19 pandemic posed severe challenges to delivery of services at Primary Care level and for achieving follow-up of patients with chronic diseases. We analysed data from the PRICOV-19 study to explore determinants of active follow-up for chronic disease patients in seven Central and Eastern European (CEE) countries during the pandemic. Pricov-19 was a cross-sectional study conducted within PC (Primary Care) practices in 37 European countries. We analysed data from 7 CEE countries (Bulgaria, Czech Republic, Hungary, Poland, Moldova, Romania, Ukraine) collected between November 2020 and December 2021. Practices were recruited through random or convenience sampling and participation of practices was voluntary. We performed descriptive statistics to identify the level of follow-up of chronic disease and what health system and practice-specific factors were associated with better follow-up. We used logistic regression and meta-analysis techniques to explore associations and heterogeneity between countries. 67. 8% out of 978 practices reported actively following up chronic patients. Positive associations were found between active follow-up and such as having more GPs (aOR = 1. 18, p-value = 0. 005), an above-average chronic patient population (aOR = 3. 13, p-value = 0. 006), adequate government support (aOR = 2. 35, p-value = 0. 001), and GPs having time for guideline reading (aOR = 0. 008, p-value = 1. 71). Patient follow-up, was influenced by different health system and practice-specific factors. The implications suggest the need for government support to enhance PC practice organisation during crises and solutions to decrease GP workload and provide tailored care for patients with chronic disease.
Semantics
Type | Source | Name |
---|---|---|
disease | MESH | chronic conditions |
disease | MESH | COVID-19 |
drug | DRUGBANK | Tropicamide |
disease | VO | population |
disease | VO | time |
disease | IDO | country |
disease | IDO | quality |